NBCA LIQUID EMBOLIC SYSTEM UNK-CNV_NBCA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a literature report with the FDA on 2017-07-07 for NBCA LIQUID EMBOLIC SYSTEM UNK-CNV_NBCA manufactured by Codman And Shurtleff, Inc.

Event Text Entries

[79272644] Article attached to this mdr: wakhloo, a. K. , perlow, a. , linfante, i. Et al. (2005). Transvenous n-butyl-cyanoacrylate infusion for complex dural carotid cavernous fistulas: technical considerations and clinical outcome. Ajnr am j neuroradiol 26:1888? 1897, september 2005. This submission is related to a literature article discovered in an effort to support the cer submission process, as such, the associated time frame of event dates includes but is not limited to 20 years. These articles are being reviewed on a monthly basis for safety signals and will be followed by monthly trending assessments as well as pms reviews. Date of event, product code, and lot number could not be obtained from the author. Unknown part number, attempts to obtain product part number were unsuccessful, udi unavailable. Conclusion: the products were not available for analysis. In addition, the lot numbers were not available; therefore, a dhr could not be performed. Neurological deficit is a known potential adverse event associated with embolization procedures. The root cause of the event could not be conclusively determined; however, the author attributed the symptoms to the occlusion of the entire carotid sinus. There is no current safety signal identified related to the reported events based on review of complaint histories for the device. Since there was no evidence to suggest the events were related to a manufacturing issue, no corrective actions will be taken at this time. This is an initial/final mdr report.
Patient Sequence No: 1, Text Type: N, H10


[79272645] In the literature article? Transvenous n-butyl-cyanoacrylate infusion for complex dural carotid cavernous fistulas: technical considerations and clinical outcome? By ajay k. Wakhloo, alain perlow, italo linfante, johnny s. Sandhu, john cameron, neil troffkin, alexander schenck, norman j. Schatz, david t. Tse, and byron l. Lam, published ajnr am j neuroradiol 26:1888? 1897, september 2005, worsening of cranial nerve palsy was reported in patient 3 post n-bca (catalog and lot not in article) embolization procedure. A (b)(6) male patient had presented with symptoms of chemosis and ophthalmoplegia. The patient had a type d-2 dural cavernous carotid fistula (dccf). Patient underwent a successful obliteration of the bilateral dccf with n-bca via one of the interior petrosal sinuses (ips) and an intercavernous approach. One week after the procedure, the patient developed bilateral worsening of ophthalmoplegia and cranial nerve (cn) vi palsy, proptosis, and chemosis. Angiography showed no filling of the fistula. The authors attributed the symptoms to the occlusion of the entire carotid sinus (cs), which the patient probably did not tolerate. The patient was treated conservatively and slowly recovered back to normal in several months.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1226348-2017-00104
MDR Report Key6693061
Report SourceLITERATURE
Date Received2017-07-07
Date of Report2017-06-12
Date of Event2005-09-01
Date Mfgr Received2017-06-12
Date Added to Maude2017-07-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKAREN ANIGBO
Manufacturer Street325 PARAMOUNT DR
Manufacturer CityRAYNHAM MA 02767
Manufacturer CountryUS
Manufacturer Postal02767
Manufacturer Phone5088288374
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNBCA LIQUID EMBOLIC SYSTEM
Generic NameTRUFILL N-BCA
Product CodeKGG
Date Received2017-07-07
Model NumberNA
Catalog NumberUNK-CNV_NBCA
Lot NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCODMAN AND SHURTLEFF, INC
Manufacturer Address325 PARAMOUNT DR RAYNHAM MA US


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2017-07-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.